Meta-Analysishigh evidence
Reassessing the risk-modifying effects of novel antidiabetic agents on asthma-COPD overlap syndrome: a dose-stratified network meta-analysis of 316,832 adults from 128 randomised trials.
EClinicalMedicine·July 1, 2026·PMID 42376494
Why it mattersClinicians managing patients with diabetes and chronic airway disease need to consider the heterogeneous respiratory effects of glucose-lowering drugs. These findings may inform agent selection to potentially reduce ACOS-related exacerbations.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled